Who owns CENTESSA PHARMACEUTICALS PLC?
- Ticker: CNTA
- CUSIP Number: 152309100
Tip: Access positions for across all investors
Analyze quarterly positions in Centessa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Centessa Pharmaceuticals stock
Who bought or sold CENTESSA PHARMACEUTICALS PLC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Medicxi Ventures Management | 20M | $226M | 0% | Mar 2024 |
|
BVF | 8.8M | $70M | -4% | Dec 2023 |
|
EcoR1 Capital | 5.6M | $45M | 0% | Dec 2023 |
|
Vida Ventures Advisors | 3.9M | $44M | 0% | Mar 2024 |
|
T. Rowe Price Associates | 2.5M | $20M | 0% | Dec 2023 |
|
Octagon Capital Advisors | 2.1M | $16M | 333% | Dec 2023 |
|
Point72 Asset Management | 1.8M | $15M | 0% | Dec 2023 |
|
Franklin Resources | 1.1M | $8.9M | 34% | Dec 2023 |
|
Artal Group | 1.0M | $8.1M | 100% | Dec 2023 |
|
Tanager Wealth Management | 696k | $5.5M | 0% | Dec 2023 |
|
Cormorant Asset Management | 562k | $4.5M | 0% | Dec 2023 |
|
Kynam Capital Management | 443k | $3.5M | -39% | Dec 2023 |
|
TD Asset Management | 186k | $1.5M | 0% | Dec 2023 |
|
Citadel Advisors | 114k | $911k | 844% | Dec 2023 |
|
Millennium Management | 43k | $338k | 100% | Dec 2023 |
|
Bank of America Corporation | 37k | $295k | -29% | Dec 2023 |
|
Goldman Sachs Group | 25k | $197k | 132% | Dec 2023 |
|
Two Sigma Investments | 17k | $131k | 42% | Dec 2023 |
|
Trexquant Investment | 14k | $114k | 100% | Dec 2023 |
|
Jump Financial | 14k | $114k | 100% | Dec 2023 |
|
Schonfeld Strategic Advisors | 13k | $101k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 11k | $85k | 5% | Dec 2023 |
|
Barclays | 6.4k | $51k | 0% | Dec 2023 |
|
China Universal Asset Management | 6.4k | $51k | 371% | Dec 2023 |
|
Quarry | 6.0k | $48k | 100% | Dec 2023 |
|
Compagnie Lombard, Odier SCA | 5.8k | $46k | 0% | Dec 2023 |
|
Cubist Systematic Strategies | 4.8k | $38k | 100% | Dec 2023 |
|
Zurcher Kantonalbank | 2.3k | $26k | 100% | Mar 2024 |
|
Advisor Group Holdings | 2.0k | $16k | -29% | Dec 2023 |
|
UBS Group | 1.6k | $13k | -40% | Dec 2023 |
|
GAMMA Investing | 1.5k | $17k | 164% | Mar 2024 |
|
Citigroup | 999.00 | $8.0k | 52% | Dec 2023 |
|
Adirondack Trust | 925.00 | $11k | 0% | Mar 2024 |
|
Global Retirement Partners | 700.00 | $7.9k | 0% | Mar 2024 |
|
Daiwa Securities Group | 211.00 | $2.0k | 0% | Dec 2023 |
|
Nbc Securities | 138.00 | $1.0k | 0% | Mar 2024 |
|
Royal Bank of Canada | 91.00 | $1.1k | 355% | Dec 2023 |
|
Caldwell Sutter Capital | 86.00 | $971.997800 | -50% | Mar 2024 |
|
Spire Wealth Management | 70.00 | $791.000000 | 0% | Mar 2024 |
|
Who sold out of Centessa Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Boxer Capital | Sep 2023 | 771k | $5.0M |